A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Seagen Inc.
AstraZeneca
Kivu Bioscience Inc.
National Cancer Institute (NCI)
Exscientia AI Limited
Sotio Biotech Inc.
National Cancer Institute (NCI)
MacroGenics
SystImmune Inc.
SN BioScience
Incyte Corporation
Janux Therapeutics
NiKang Therapeutics, Inc.
Novelty Nobility, Inc.
Pfizer
Hoffmann-La Roche
University of Virginia
Incyte Corporation
National Cancer Institute (NCI)
BeiGene
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
Xencor, Inc.
HiberCell, Inc.
National Cancer Institute (NCI)
Zhejiang University
University of Florida
MacroGenics
Syros Pharmaceuticals
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Gossamer Bio Inc.
Genocea Biosciences, Inc.
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
AstraZeneca
Abramson Cancer Center at Penn Medicine
MedImmune LLC
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Pfizer
Merrimack Pharmaceuticals
Masonic Cancer Center, University of Minnesota